Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, the Netherlands; Department of Surgery, University Medical Center Utrecht, Utrecht University, the Netherlands.
Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, the Netherlands.
Int J Radiat Oncol Biol Phys. 2020 Apr 1;106(5):998-1009. doi: 10.1016/j.ijrobp.2019.12.038. Epub 2020 Jan 25.
Accurate preoperative prediction of pathologic response to neoadjuvant chemoradiotherapy (nCRT) in patients with esophageal cancer could enable omission of esophagectomy in patients with a pathologic complete response (pCR). This study aimed to evaluate the individual and combined value of F-fluorodeoxyglucose positron emission tomography with integrated computed tomography (F-FDG PET/CT) and diffusion-weighted magnetic resonance imaging (DW-MRI) during and after nCRT to predict pathologic response in patients with esophageal cancer.
In this multicenter prospective study, patients scheduled to receive nCRT followed by esophagectomy for esophageal cancer underwent F-FDG PET/CT and DW-MRI scanning before the start of nCRT, during nCRT, and before esophagectomy. Response to nCRT was based on histopathologic evaluation of the resection specimen. Relative changes in F-FDG PET/CT and DW-MRI parameters were compared between patients with pCR and non-pCR groups. Multivariable ridge regression analyses with bootstrapped c-indices were performed to evaluate the individual and combined value of F-FDG PET/CT and DW-MRI.
pCR was found in 26.1% of 69 patients. Relative changes in F-FDG PET/CT parameters after nCRT (Δ standardized uptake value [SUV]P = .016, and Δ total lesion glycolysis P = .024), as well as changes in DW-MRI parameters during nCRT (Δ apparent diffusion coefficient [ADC]P = .008) were significantly different between pCR and non-pCR. A c-statistic of 0.84 was obtained for a model with ΔADC, ΔSUV, and histology in classifying patients as pCR (versus 0.82 for ΔADC and 0.79 for ΔSUV alone).
Changes on F-FDG PET/CT after nCRT and early changes on DW-MRI during nCRT can help identify pCR to nCRT in esophageal cancer. Moreover, F-FDG PET/CT and DW-MRI might be of complementary value in the assessment of pCR.
准确预测接受新辅助放化疗(nCRT)的食管癌患者的病理反应,有助于对病理完全缓解(pCR)患者避免行食管切除术。本研究旨在评估 nCRT 期间和结束后 F-氟代脱氧葡萄糖正电子发射断层扫描与整合计算机断层扫描(F-FDG PET/CT)和弥散加权磁共振成像(DW-MRI)在预测食管癌患者病理反应方面的单独和联合价值。
本多中心前瞻性研究纳入了计划接受 nCRT 治疗后行食管切除术的食管癌患者,在 nCRT 开始前、进行中以及手术前分别行 F-FDG PET/CT 和 DW-MRI 扫描。nCRT 反应基于切除标本的组织病理学评估。比较 pCR 与非 pCR 组患者的 F-FDG PET/CT 和 DW-MRI 参数的相对变化。采用 Bootstrap 法进行多变量 Ridge 回归分析,评估 F-FDG PET/CT 和 DW-MRI 的单独和联合价值。
69 例患者中,pCR 发生率为 26.1%。nCRT 后 F-FDG PET/CT 参数的相对变化(Δ标准化摄取值 SUVP =.016,Δ总病灶糖酵解 P =.024),以及 nCRT 期间 DW-MRI 参数的变化(Δ表观扩散系数 ADC P =.008)在 pCR 与非 pCR 组之间存在显著差异。基于 ΔADC、ΔSUV 和组织学的模型在区分 pCR 患者方面具有 0.84 的 C 统计量(0.82 用于 ΔADC,0.79 用于 ΔSUV 单独)。
nCRT 后 F-FDG PET/CT 的变化和 nCRT 期间 DW-MRI 的早期变化有助于识别食管癌患者的 nCRT 病理完全缓解。此外,F-FDG PET/CT 和 DW-MRI 在评估 pCR 方面可能具有互补价值。